Calculate Well’s score for PE (BOX1)

Slides:



Advertisements
Similar presentations
Venous thromboembolic diseases: Pulmonary embolism
Advertisements

Atrial Fibrillation Cardiovascular ISCEE 26th October 2010.
The patient with shortness of breath. Differential diagnosis Asthma Asthma COPD COPD Pneumonia Pneumonia Heart failure Heart failure PE PE Other Other.
Controversies in the management of Pulmonary Embolism
SEPSIS KILLS program Paediatric Inpatients
VTE Toolkit Chapter Five Venous Disease Coalition
Management of Stroke and Transient Ischaemic Attack Sam Thomson.
P ULMONARY THROMBOEMBOLISM SPECIFIC SITUATIONS Dr.E.Shabani.
The PERC Rule. The paper Kline et al Journal of Thrombosis and Haemostasis 2008 Prospective Multicenter Evaluation of the Pulmonary Embolism Rule Out.
Clinical Knowledge Summaries CKS Pulmonary embolism (PE)
Pam Charity, MD Cathryn Caton, MD, MS.  Define pneumonia  Review criteria for diagnosis  Review criteria for admission  Review treatment options.
DPT 732 SPRING 2009 S. SCHERER Deep Vein Thrombosis.
D-dimer in the Diagnosis of Pulmonary Embolism Cheryl Pollock PGY-3.
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Primary Aim To compare outcomes of participants with symptoms of stable angina or angina equivalent evaluated with an anatomic imaging strategy using CCTA.
Hospital at Home for COPD Dr Tarek Saba Consultant Chest Physician Sister Pauline Berry Respiratory Nurse Specialist.
Case Report Pneumology Dr. David Tran A&E, FVHospital Medical meeting September 28 th, 2011.
Shortness of breath By: Tina Tarazi. Patient is a 49 year old F with PMH of NSCLC s/p chemotherapy and radiation and right frontal lobe resection in 12/2013.
Moderate Pulmonary Embolism Treated with Thrombolysis (MOPETT) Trial Mohsen Sharifi, Curt Bay, Laura Skrocki, Farnoosh Rahimi, Mahshid Mehdipour A.T.Still.
PULMONARY EMBOLI Kenney Weinmeister M.D.. PULMONARY EMBOLI w Over 500,000 cases per year. w Results in 200,000 deaths. w Mortality without treatment is.
DVT Prevention and Anticoagulant Management
Excluding the Diagnosis of Pulmonary Embolism: Is There a Magic Ball? COPYRIGHT © 2015, ALL RIGHTS RESERVED From the Publishers of.
Module IV - Identification of Patients for Buprenorphine Treatment BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Radiology “Dos and Don’ts” Clinical Governance Medical Division 18 July 2013.
D NGUE WORKSHOP 2015 ID HSB OPD – CASE 5 ID HSB 2015.
PULMONARY EMBOLUS Quick revision guide – Chris Scott.
Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing June 2012 NICE clinical guideline.
Antithrombotic Therapy for VTE: CHEST Guidelines 2016
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
Key facts about AKI 5 Facts about acute kidney injury (AKI), formerly known as "acute renal failure“ Up to 20% of hospital admissions have AKI Up to 25%
Venous Thromboembolic Disease: The Role of Novel Anticoagulants Grant M. Greenberg MD, MA, MHSA.
Outpatient DVT assessment & treatment Daniel Gilada.
ONE YEAR EXPERIENCE OF A “ SAFETY NET” PROTOCOL FOR ABNORMAL CHEST RADIOGRAPHS (CXR) H Singh, SCO Taggart, PM Turkington, K Peplow, R Chisholm, BR O’ Driscoll.
Diagnosis Recitation. The Dilemma At the conclusion of my “diagnosis” presentation during the recent IAPA meeting, a gentleman from the audience asked.
Pulmonary Embolism Presentation to Diagnosis
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
HIV acutely unwell pathway Sussex HIV Network This pathway applies to all patients other than those listed in non-acute pathway All HIV+ patients with.
CRT 2012 Venous Disease.
The VERITY Steering Committee
Prandoni et al NEJM 375;16 October 20, 2016
Diagnosis of venous thromboembolism
EOL care Closing the Gap 2b.
Defining hypertension
Clinical Knowledge Summaries CKS Pulmonary embolism (PE)
The Evaluation of Suspected Pulmonary Embolism
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
Quality of Referrals Guideline Congruence of referrals to TIAMS clinic
or who have clinical observations outside normal limits.
Pulmonary Thrombo-Embolism
Confirmed VTE Treatment Pathway
Wessex Regional All Cause Deterioration (including Sepsis) Guidance
OBMC Core Measures January 2015
Generic Sepsis Screening & Action Tool
Reducing Unnecessary Testing & Hospitalizations
Thrombolysis therapy for Pulmonary Embolism
GHS Outpatient Enoxaparin Program
Lung Cancer Pathway Dr Heather Harris - Consultant Radiologist
Principal recommendations
Takes place two weeks after consultation 2
West Essex Frailty Pathway: COPD
General Imaging Information
EMERGENCY Awn khawaldeh.
Consultant Clinical Biochemist
ED Consultant (Imperial)
ACCORD All Cause Clinical & Organisational Response to Deterioration
Nottingham City Care Integrated Respiratory Service and Home Oxygen Service Zoe Styles Senior Physiotherapist.
GP access to body CT for suspected malignancy
Principal recommendations
Presentation transcript:

Calculate Well’s score for PE (BOX1) Suspected Pulmonary Embolus Pathway for Adults Eligible Patients must have: Basic bloods (FBC, IP,) ECG CXR Senior decision (consultant/ ST4+) to commence on pathway Exclusions to pathway: Age < 16 years Pregnant (See separate pathway) Haemodynamic instability Calculate Well’s score for PE (BOX1) 0-1.5 2-4 4.5+ Any positive PERC criteria? Age > 50yrs HR > 100bpm O2 sats < 95% Unilateral leg swelling Haemoptysis Trauma or surgery within previous 4 weeks Previous DVT/PE Hormone use e.g. COCP Bleed patient and request D-dimer sPESI = 0 (BOX 2) patients may be transferred to ACC if open prior to result. For patients definitely requiring admission request MAU bed if not already done so Start on LMWH 1mg/kg BD if no C/I sPESI = 0 (BOX 2) and no contradication to discharge (Box 5) sPESI ≥ 1 (BOX 2) or other contradication to discharge (Box 5) Yes Yes D-dimer greater than 500ng/dl or age x 10 (if patient >50 years)? E.g 85 year old = d dimer cut off of 850ng/dl Suitable for outpatient care ACC referral if patient in ED ACC to request imaging (see BOX 4) Give safety net advice Admit under medical team. Do they need escalation to HDU/ ITU? No No PE excluded, consider alternative diagnosis BOX 1 Well’s score for PE Signs and symptoms of DVT 3 PE most likely diagnosis HR > 100 1.5 Immobilisation >3 days or surgery < 4 weeks ago Previous DVT/PE Haemoptysis 1 Malignancy (treatment in last 6 months/ palliative) TOTAL ______ BOX 2 sPESI score Not suitable for outpatient care if ANY of the following: Tachycardia >110bpm Systolic BP <100mmHg SaO2 <90% Age > 80 years Chronic lung or heart disease Cancer (history or active)

BOX 3 Anticoagulation BOX 4 Imaging Patients awaiting imaging should receive anticoagulation while awaiting imaging unless imaging is available immediately or there is a major contraindication to anticoagulation. Enoxaparin 1mg/kg BD if no contraindication (altered dosing in renal impairment, pregnancy and extremes of weight- check BNF/ discuss with pharmacist) Prescribing Advice for all anticoagulation See BNF for drug interactions If the patient is at risk of bleeding the clinician needs to weigh up risk vs. benefit. Could early imaging be obtained to potentially negate need for anticoagulation? BOX 4 Imaging Timing: All patients with suspected PE in whom radiological imaging is required after initial assessment should be imaged within 24 hours. Stable patients assessed out of normal working hours should be imaged on the first available list the following day. Unstable patients should ideally be imaged within 1 hour. Where a patients’ need for imaging is considered urgent, a senior clinician, should discuss the case with the radiologist on call Imaging modality: Age under 50 and no significant co-morbid cardiorespiratory disease with a normal chest radiograph: VQ SPECT scan if available (Not available after hours) Age over 50 or significant co-morbid cardiorespiratory disease, or abnormal chest radiograph: CTPA. Impaired renal function or previous reaction to contrast discuss with radiologist. Box 5 Do not discharge following groups of patients being treated with anticoagulation for suspected pulmonary embolus Active bleeding or risk of major bleeding On full-dose anticoagulation at the time of the suspected PE Severe pain (requiring IV opioids) Other medical comorbidities requiring hospital admission Chronic kidney disease (CKD) stage 4 or 5 or severe liver disease. Heparin induced thrombocytopenia within the last year and where there is no alternative to repeating heparin treatment. Social reasons which may include inability to return home, inadequate care at home, lack of telephone communication or concern over treatment compliance.